James Molloy
Stock Analyst at Alliance Global Partners
(0.42)
# 4,036
Out of 4,876 analysts
33
Total ratings
20.59%
Success rate
-43.8%
Average return
Main Sectors:
Stocks Rated by James Molloy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IGC IGC Pharma | Reiterates: Buy | $3.5 | $0.31 | +1,032.69% | 2 | Mar 6, 2025 | |
| INTS Intensity Therapeutics | Initiates: Buy | $8.5 | $0.32 | +2,556.25% | 1 | Jan 13, 2025 | |
| VTVT vTv Therapeutics | Initiates: Buy | $35 | $14.54 | +140.72% | 1 | Dec 9, 2024 | |
| GOVX GeoVax Labs | Initiates: Buy | $15 | $0.96 | +1,462.50% | 1 | Nov 11, 2024 | |
| INMB INmune Bio | Initiates: Buy | $20 | $5.33 | +275.23% | 1 | Oct 21, 2024 | |
| SCLX Scilex Holding Company | Initiates: Buy | $490 | $6.05 | +7,999.17% | 1 | Oct 16, 2024 | |
| TNXP Tonix Pharmaceuticals Holding | Maintains: Buy | $600 → $1,100 | $34.89 | +3,052.77% | 7 | Jul 22, 2024 | |
| PED PEDEVCO | Initiates: Buy | $1.75 | $0.67 | +162.25% | 1 | Jul 17, 2024 | |
| PXS Pyxis Tankers | Initiates: Buy | $10 | $2.82 | +254.61% | 1 | Jul 17, 2024 | |
| CHRO Channel Therapeutics | Initiates: Buy | n/a | $1.35 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $14 | $0.95 | +1,373.68% | 2 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.22 | +2,359.02% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7.5 | $1.90 | +294.74% | 1 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $5.75 | +247.83% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.95 | +310.26% | 1 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $7 | $3.25 | +115.38% | 2 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.16 | +6,801.91% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $0.34 | +4,640.74% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $0.43 | +3,155.81% | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $0.74 | +1,927.03% | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,400 | $9.27 | +90,514.89% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $150 | $1.85 | +8,008.11% | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $938 | $1.24 | +75,504.84% | 1 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $2.23 | +1,021.08% | 1 | Oct 4, 2021 |
IGC Pharma
Mar 6, 2025
Reiterates: Buy
Price Target: $3.5
Current: $0.31
Upside: +1,032.69%
Intensity Therapeutics
Jan 13, 2025
Initiates: Buy
Price Target: $8.5
Current: $0.32
Upside: +2,556.25%
vTv Therapeutics
Dec 9, 2024
Initiates: Buy
Price Target: $35
Current: $14.54
Upside: +140.72%
GeoVax Labs
Nov 11, 2024
Initiates: Buy
Price Target: $15
Current: $0.96
Upside: +1,462.50%
INmune Bio
Oct 21, 2024
Initiates: Buy
Price Target: $20
Current: $5.33
Upside: +275.23%
Scilex Holding Company
Oct 16, 2024
Initiates: Buy
Price Target: $490
Current: $6.05
Upside: +7,999.17%
Tonix Pharmaceuticals Holding
Jul 22, 2024
Maintains: Buy
Price Target: $600 → $1,100
Current: $34.89
Upside: +3,052.77%
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $1.75
Current: $0.67
Upside: +162.25%
Pyxis Tankers
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $2.82
Upside: +254.61%
Channel Therapeutics
Jun 18, 2024
Initiates: Buy
Price Target: n/a
Current: $1.35
Upside: -
Jan 4, 2024
Maintains: Buy
Price Target: $9 → $14
Current: $0.95
Upside: +1,373.68%
Dec 11, 2023
Initiates: Buy
Price Target: $30
Current: $1.22
Upside: +2,359.02%
Jul 17, 2023
Initiates: Buy
Price Target: $7.5
Current: $1.90
Upside: +294.74%
May 24, 2023
Reiterates: Buy
Price Target: $20
Current: $5.75
Upside: +247.83%
Nov 15, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $1.95
Upside: +310.26%
Nov 4, 2022
Maintains: Buy
Price Target: $10 → $7
Current: $3.25
Upside: +115.38%
Nov 1, 2022
Initiates: Buy
Price Target: $80
Current: $1.16
Upside: +6,801.91%
Nov 1, 2022
Initiates: Buy
Price Target: $16
Current: $0.34
Upside: +4,640.74%
Oct 20, 2022
Initiates: Buy
Price Target: $14
Current: $0.43
Upside: +3,155.81%
Oct 13, 2022
Initiates: Buy
Price Target: $15
Current: $0.74
Upside: +1,927.03%
Sep 7, 2022
Initiates: Buy
Price Target: $8,400
Current: $9.27
Upside: +90,514.89%
Aug 25, 2022
Initiates: Buy
Price Target: $150
Current: $1.85
Upside: +8,008.11%
Jun 1, 2022
Initiates: Buy
Price Target: $938
Current: $1.24
Upside: +75,504.84%
Oct 4, 2021
Initiates: Buy
Price Target: $25
Current: $2.23
Upside: +1,021.08%